The aim of this study was to evaluate the health-related quality of life (HRQoL) of Malaysian patients with type 2 diabetes mellitus (T2DM) who have cardiovascular disease (CVD), as well as identify the determinants of HRQoL among this cohort of patients.
I NTRO D U C TIO N
Diabetes mellitus (DM) is one of the fastest growing major public health problems worldwide. It is predicted that approximately 552 million adults will have DM by 2030. (1) There are three types of DM, of which type 2 DM (T2DM) is the most prevalent. Due to its prevalence, the cost of managing the disease results in considerable economic and financial burden to the society and healthcare sector. The disease also causes varying amounts of distress to its sufferers.
Although there have been improvements in the quality of care of T2DM patients, chronic long-term complications remain an important and costly problem to both the individual and society. (2) Epidemiological studies have indicated that patients with T2DM have a 2-4 times higher risk of cardiovascular disease (CVD) mortality than those without DM, (3) (4) (5) (6) (7) with CVD being the principal cause of death in patients with T2DM. (3, (8) (9) (10) (11) (12) (13) CVD is associated with premature mortality and a reduced quality of life (QoL). CVD not only results in physical disability, heavy economic cost, lifelong medication, and psychological burden, it also leads to compromised health-related quality of life (HRQoL). (14) Objective clinical measures of cardiovascular status, such as those that use the New York Heart Association classification, (15) is not only to extend life, but also to relieve symptoms and improve the patient's function and ability to participate in daily life activities. (16) Consequently, HRQoL measures have gained increasing attention as outcome variables in studies evaluating modern treatments of CVD, especially studies on coronary artery disease (CAD). (16) Although HRQoL has been increasingly applied as an indicator of health outcome in recent years, and HRQoL reflects 'total welfare' through its capture of all relevant
The association of cardiovascular disease with impaired health-related quality of life among patients with type 2 diabetes mellitus dimensions of health of an individual, little is known about the relationship between CVD and HRQoL in T2DM patients.
We thus conducted the present study to compare the HRQoL of T2DM patients with and without CVD. The possible differences in the quality and quantity of suffering resulting from the patient's illness were examined and evaluated using the general, non-disease-specific 15D instrument. (17) As the present study is an original research, we believe that it will play an important role in the improvement of T2DM patient care
and provide evidence on the need for cardiac rehabilitation programmes in Malaysia. The data obtained in the present study can also be used to identify the features of the disease and the treatment strategies that future research should concentrate on in the effort to improve the well-being of T2DM patients in a more cost-effective manner.
M e Th O Ds
The present cross-sectional study comprised a systematic random sample of 313 T2DM patients from two tertiary hospitals in Klang Valley, Malaysia (one in the federal territory of Kuala Lumpur, and the other in Selangor). The study cohort contained patients from the three main ethnic groups in Malaysia -Malay, Chinese and Indian. T2DM patients were identified via the hospitals' medical records. Identified patients were recruited by trained, multilingual interviewers during the patients' routine visits to the hospitals between June 2010 and April 2011. Patients who were ambulatory and diagnosed with T2DM were included in the present study.
The following patients were excluded: (a) patients with type 1 DM or gestational DM; (b) patients who were pregnant or lactating; (c) patients with the following diseases/conditions: nonatherosclerotic heart diseases (e.g. rheumatic heart disease and congestive heart failure secondary to thyrotoxicosis), atrial fibrillation, venous thromboembolism, nonischaemic cardiomyopathy, valvular heart disease, cardiac dysrhythmias, inflammatory heart disease (e.g. endocarditis, pericarditis and myocarditis), congenital heart disease, embolic and haemorrhagic strokes, malignant disease, severe psychiatric illness and dementia; and (d) patients with a prosthetic heart valve.
Prior to the interview session, written informed consent was obtained from all patients who agreed to participate in the present study. All participating patients were informed about the nature of the study, and participation was completely intake (using the 24-hr dietary recall method), (18) level of physical activity (using the International Physical Activity Questionnaire), (19) 15D score (single index number) over all the dimensions. The maximum score is 1 (i.e. no problems on any dimension) and the minimum score is 0 (i.e. dead). (17) The minimal clinically important difference in the overall score of the 15D instrument was set at 0.03. In other words, a
change of approximately ± 0.03 in the score was regarded as important because, on average, such a change in the score indicates a tangible difference. (21) As national scoring weights for this instrument were not available, the original Finnish scoring was used in the present study. Based on repeat measurements, the 15D instrument has been shown to be highly reliable, sensitive and responsive to change. (17, (21) (22) (23) To minimise missing data and inter-examiner error in the present study, all interviews were conducted by the same group of interviewers, all of whom were trained for the purposes of the study. The study cohort was divided into tertiles and the associations of CVD with other selected variables were analysed (highest 15D tertile vs the middle and lowest 15D tertiles). In the present study, the Cronbach's alpha reliability coefficient of the 15D instrument was 0.810.
All statistical analyses were performed using IBM SPSS 
R e sU lT s
Among the 313 T2DM patients in our cohort, 113 (36.1%) had CVD and 200 (63.9%) did not. The sociodemographic, clinical, and laborator y characteristics of the study cohort are presented in Table III .
The mean age of all of the patients was 55.7 ± 9.2 years (range 30-78 years) and 52.1% were women. In terms of ethnicity, approximately half of the patients were of Malay ethnicity, followed by patients of Indian and Chinese ethnicities. The majority of our study cohort had a low educational status (i.e. a secondary school education or lower). The majority of the The prevalences of CVD and its components, according to the 15D tertile groups, are shown in Table IV . CVD prevalence was significantly lower in the highest 15D tertile (2.2%) when compared to the lowest and the middle 15D tertiles (23.3% and 10.5%, respectively) (p < 0.001). Similarly, the prevalence of CAD increased from 1.6% in the highest 15D
tertile to 20.8% in the lowest 15D tertile (p < 0.001). Similar trends were observed for cerebrovascular disease and PVD.
In the multinomial logistic regression analysis using backward stepwise method, CVD was found to be significantly associated with impaired HRQoL (OR 11.746; p < 0.001) (Table V) 
D I sCU s s IO N
HRQoL is defined as an individual's perception of his/her symptoms, well-being, and physical and mental functional capacity; it is conceptually based on the World Health Organization's definition of health. (24) The concept of HRQoL is wide-ranging, with different fields of human life influencing it.
Its multidimensional nature and complexity present as a challenge for researchers. DM has a marked influence on HRQoL. The symptoms and accompanying complications of DM, together with its therapy, affect various aspects of an individual's HRQoL. (25) Since CVD is the most prevalent complication in T2DM, the present study looked into the influence CVD has on the HRQoL of T2DM patients.
The findings of the present study confirmed that CVD was significantly associated with impaired HRQoL. T2DM patients with CVD had poorer HRQoL than those without CVD, with respect to all the dimensions of the 15D instrument. Impaired
HRQoL was also significantly associated with advanced age and increased duration of T2DM. In our study, we found that instrument. Earlier studies attributed impaired HRQoL in T2DM patients to the severity of DM and the manifestation of diabetic CVD. (26, 27) It is worth noting that the findings of the present study show that CVD is the strongest predictor of impaired HRQoL. This is in accordance with the findings of studies by Stafford et al and Li et al. (28, 29) In the Stafford et al study, patients with a stroke, heart attack or angina diagnosis were found to have the greatest decreases in EQ-5D HRQoL index scores. (28) The study by Li et al highlighted that individuals with CVD had an approximately two-to four-fold increased likelihood of impaired HRQoL than individuals without CVD. (29) Advanced age and a longer duration of T2DM were also found to have a detrimental impact on the HRQoL of our study cohort. This is in agreement with other reports. The association between obesity and HRQoL has been documented in several studies. (36, 37) This association is consistent with our finding that elevated BMI, an indicator of obesity, is closely related to impaired HRQoL. Furthermore, in an
American review of the effect of obesity on HRQoL in T2DM, the authors reported that decreased HRQoL was observed with increased body weight in all the studies reviewed. (38) It is not surprising that cardiorespiratory performance and physical functioning may be impaired by obesity. This is because obese patients need to carry more weight while performing activities, and their larger physical size may make performing certain activities difficult. They may also experience low maximal oxygen uptake and psychosocial stress. All of this justifies the adverse effects of obesity on HRQoL.
In the present multiethnic hospital-based study, we also found that Indian T2DM patients experienced lower HRQoL 
If patients scored poorly in the breathing dimension of the 15D instrument, these patients probably suffered from coronary ischaemia and/or heart failure. The ischaemia may be asymptomatic or present with pain. A plausible explanation for painless infarction and ischaemic episodes in DM patients is autonomic neuropathy with involvement of the sensory supply to the heart. (40, 41) Meanwhile, a significant decrease in the mobility, usual activities and sexual activity dimensions may be due to the presence of angina pectoris, which could result in deterioration of physical capacity and effort tolerance, negatively affecting the HRQoL of a patient with CVD. In our study, patients with CVD also scored poorly in the discomfort and symptoms, and vitality dimensions when compared to patients without CVD. This indicates that patients experiencing threatening illnesses such as CAD, stroke or PVD have a worsened zest for life. It is also possible that lower vitality and decreased sexual activity may both be due to the adverse reactions of drugs, such as beta blockers and statins, which were commonly taken by patients with CVD in our cohort who were on more aggressive treatments.
In our study, T2DM patients with CVD also had poor 15D scores documented in the hearing, vision and mental function dimensions. Deterioration in hearing is multifactorial, and may be explained by advanced age and/or adverse reactions from medication use (e.g. frusemide). Ageing may also be a contributing factor to poor vision, along with glaucoma and diabetic retinopathy. Poor scores in mental function was not unexpected, as cognitive decline is often seen in elderly patients.
Moreover, patients with CVD may experience silent ischaemia to brain tissues and speech difficulties secondary to stroke.
It is difficult to explain the mechanisms behind impaired sleeping among T2DM patients with CVD. (42, 43) we found that depression and distress were higher among the T2DM patients with CVD than those without CVD. This may primarily be due to daily medication requirements, dietary restrictions, active healthcare resource utilisation, and a sense of helplessness in dealing with the diseases.
The most noteworthy finding of the present study is the The present study is limited by its cross-sectional nature.
Although the assumption that CVD and its disorders precede declines in HRQoL has been supported by longitudinal studies, (28) the temporal relationships could not be tested in the present study. Further prospective studies should be carried out to assess these temporal relationships. Another limitation is that only one measure of HRQoL (i.e. the 15D instrument) was used in the present study to test for comparability. While the 15D instrument has been extensively used in international studies, it is possible that alternative measures of HRQoL may accentuate different health conditions. It is important to keep in mind that the 15D instrument is not DM-specific, and it may thus reflect problems related to other conditions.
In conclusion, the presence of CVD was found to be significantly associated with a lower HRQoL in T2DM patients.
Tertiary prevention is therefore of great importance in the effort to minimise the potential deterioration of HRQoL of T2DM patients, especially if the patient is also afflicted with CVD.
Patients should also be empowered with adequate knowledge to enable the cultivation of better self-management skills, so as to further enhance their HRQoL.
R e FeR e N Ce s

